Literature DB >> 10701657

Anesthesia induced retrograde amnesia is ameliorated by ephrinA5-IgG in mice: EphA receptor tyrosine kinases are involved in mammalian memory.

R Gerlai1, A McNamara.   

Abstract

EphA receptors and their ephrin-A ligands were previously thought to play a role only in embryonic development of the brain. Recently, however, these proteins were shown to be expressed in the adult mouse brain, primarily in the hippocampus, and were implicated in hippocampal synaptic plasticity and learning. What aspects of learning EphA receptors mediate have not been studied? Using the fear conditioning paradigm we demonstrate that EphA receptors play roles in memory. We show that post-training surgical anesthesia leads to robust context specific retrograde amnesia in mice, and post-anesthesia activation of EphA receptors induces a significant amelioration of this amnesia. As acquisition was left unaffected and performance factors were found unaltered, we suggest that the amelioration was due to changes in cognition leading to improved memory. Our data represent the first pieces of evidence for the involvement of EphA receptor tyrosine kinase receptors in mammalian memory, a finding that opens a new avenue into the functional analysis of the largest receptor tyrosine kinase subfamily in the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701657     DOI: 10.1016/s0166-4328(99)00139-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

Review 1.  Bidirectional ephrin/Eph signaling in synaptic functions.

Authors:  Jason Aoto; Lu Chen
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

2.  In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos.

Authors:  Jyotshnabala Kanungo; Susan Lantz; Merle G Paule
Journal:  Neurotoxicol Teratol       Date:  2011-08-27       Impact factor: 3.763

3.  Heat shock protein 72 overexpression prevents early postoperative memory decline after orthopedic surgery under general anesthesia in mice.

Authors:  Marcela P Vizcaychipi; Lijun Xu; George E Barreto; Daqing Ma; Mervyn Maze; Rona G Giffard
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

4.  The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.

Authors:  Yi Shu; Bo Xiao; Qian Wu; Tiantian Liu; Yang Du; Haiyun Tang; Si Chen; Li Feng; Lili Long; Yi Li
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

5.  Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.

Authors:  Katie J Schenning; Sarah Holden; Brett A Davis; Amelia Mulford; Kimberly A Nevonen; Joseph F Quinn; Jacob Raber; Lucia Carbone; Nabil J Alkayed
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia.

Authors:  Barbara Szepietowska; Wanling Zhu; Jan Czyzyk; Tore Eid; Robert S Sherwin
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

7.  Crocins, the Bioactive Components of Crocus sativus L., Counteract the Disrupting Effects of Anesthetic Ketamine on Memory in Rats.

Authors:  Nikolaos Pitsikas; Petros A Tarantilis
Journal:  Molecules       Date:  2021-01-20       Impact factor: 4.411

8.  Role of synaptic plasticity and EphA5-ephrinA5 interaction within the ventromedial hypothalamus in response to recurrent hypoglycemia.

Authors:  Barbara Szepietowska; Tamas L Horvath; Robert S Sherwin
Journal:  Diabetes       Date:  2013-11-12       Impact factor: 9.461

9.  EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy.

Authors:  Li Feng; Yi Shu; Qian Wu; Tiantian Liu; Hongyu Long; Huan Yang; Yi Li; Bo Xiao
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.